The Valley Desk

NCT02601937 · Interventional trial

EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma

Overall registry status Completed

Phase 1

Conditions INI1-negative Tumors, Malignant Rhabdoid Tumor of Ovary, Rhabdoid Tumors, Synovial Sarcoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov